Joshua T. Brumm, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 212,500 shares at $12.46 ($2.6M) on 2022-10-10, disclosed to the SEC on 2022-10-11.
Open-market sale of $2.6M DYN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.37 | 14,200 | $190K | 7.2% |
| 2 | $0.00 | 2,500 | $0 | 0.0% |
| 3 | $12.46 | 195,800 | $2.4M | 92.8% |
| Total | $12.37 avg | 212,500 | $2.6M | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |